Harvest Management LLC lowered its position in shares of Biohaven Ltd. (NYSE:BHVN – Free Report) by 3.2% in the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 15,100 shares of the company’s stock after selling 500 shares during the quarter. Biohaven comprises 0.6% of Harvest Management LLC’s holdings, […]
Biohaven's (BHVN) "Overweight" Rating Reiterated at Cantor Fitzgerald theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Reports new positive interim data from the ongoing Phase 1 study of BHV-1300, Biohaven s lead investigational drug from its Molecular Degrader of Extracellular.